XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statements Of Changes In Stockholders' Deficit - USD ($)
Total
Series A [Member]
Series B [Member]
Common Stock [Member]
Series A [Member]
Common Stock [Member]
Series B [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Balance, Shares at Dec. 31, 2021       0 7,503,750    
Balance at Dec. 31, 2021 $ 23,207     $ 0 $ 750 $ 24,250 $ (1,793)
Sale of 13,850,000 Private Placement Warrants 13,850,000         13,850,000  
Forfeiture of Founder Shares, Shares         (3,750)    
Compensation Expense – Fair value of assigned Founder Shares to Apeiron 362,500         362,500  
Fair value of Public Warrants at issuance 8,100,000         8,100,000  
Allocated value of transaction costs to Series A common stock (505,049)         (505,049)  
Remeasurement of Series A common stock to redemption amount (30,799,058)         (21,831,701) (8,967,357)
Net income (loss) (1,025,824)           (1,025,824)
Balance, Share at Mar. 31, 2022       0 7,500,000    
Balance at Mar. 31, 2022 (9,994,224)     $ 0 $ 750 0 (9,994,974)
Balance, Shares at Dec. 31, 2021       0 7,503,750    
Balance at Dec. 31, 2021 23,207     $ 0 $ 750 24,250 (1,793)
Net income (loss) (570,322) $ (450,395) $ (119,927)        
Balance, Share at Sep. 30, 2022       0 7,500,000    
Balance at Sep. 30, 2022 (10,641,743)     $ 0 $ 750 0 (10,642,493)
Balance, Shares at Dec. 31, 2021       0 7,503,750    
Balance at Dec. 31, 2021 23,207     $ 0 $ 750 24,250 (1,793)
Remeasurement of Series A common stock to redemption amount (33,896,988)            
Balance, Share at Dec. 31, 2022       0 7,500,000    
Balance at Dec. 31, 2022 (11,179,412)     $ 0 $ 750 0 (11,180,162)
Balance, Shares at Mar. 31, 2022       0 7,500,000    
Balance at Mar. 31, 2022 (9,994,224)     $ 0 $ 750 0 (9,994,974)
Net income (loss) (196,919)           (196,919)
Balance, Share at Jun. 30, 2022       0 7,500,000    
Balance at Jun. 30, 2022 (10,191,143)     $ 0 $ 750 0 (10,191,893)
Remeasurement of Series A common stock to redemption amount (1,103,021)           (1,103,021)
Net income (loss) 652,421 521,937 130,484       652,421
Balance, Share at Sep. 30, 2022       0 7,500,000    
Balance at Sep. 30, 2022 (10,641,743)     $ 0 $ 750 0 (10,642,493)
Balance, Shares at Dec. 31, 2022       0 7,500,000    
Balance at Dec. 31, 2022 (11,179,412)     $ 0 $ 750 0 (11,180,162)
Remeasurement of Series A common stock to redemption amount (2,554,544)           (2,554,544)
Net income (loss) 2,070,528           2,070,528
Balance, Share at Mar. 31, 2023       0 7,500,000    
Balance at Mar. 31, 2023 (11,663,428)     $ 0 $ 750 0 (11,664,178)
Balance, Shares at Dec. 31, 2022       0 7,500,000    
Balance at Dec. 31, 2022 (11,179,412)     $ 0 $ 750 0 (11,180,162)
Remeasurement of Series A common stock to redemption amount (3,942,803)            
Net income (loss) 2,828,701 2,437,328 391,373        
Balance, Share at Sep. 30, 2023       7,499,999 1    
Balance at Sep. 30, 2023 (15,058,228)     $ 749 $ 1 0 (15,058,978)
Balance, Shares at Mar. 31, 2023       0 7,500,000    
Balance at Mar. 31, 2023 (11,663,428)     $ 0 $ 750 0 (11,664,178)
Remeasurement of Series A common stock to redemption amount (1,180,703)           (1,180,703)
Stockholder non-redemption agreement 1,378,126         1,378,126  
Stockholder non-redemption agreement (1,378,126)         (1,378,126)  
Excise tax (2,764,714)           (2,764,714)
Conversion of Series Class B shares to Series Class A Non-redeemable shares, Shares       7,499,999 (7,499,999)    
Conversion of Series Class B shares to Series Class A Non-redeemable shares       $ 749 $ (749)    
Net income (loss) 802,803           802,803
Balance, Share at Jun. 30, 2023       7,499,999 1    
Balance at Jun. 30, 2023 (14,806,042)     $ 749 $ 1 0 (14,806,792)
Remeasurement of Series A common stock to redemption amount (207,556)           (207,556)
Net income (loss) (44,630) $ (44,630) $ 0       (44,630)
Balance, Share at Sep. 30, 2023       7,499,999 1    
Balance at Sep. 30, 2023 $ (15,058,228)     $ 749 $ 1 $ 0 $ (15,058,978)